NEW YORK (GenomeWeb) – Proteomics firm Biognosys said today it has raised $5 million in an extended Series C financing round.

The company said it plans to use the funds to extend its commercial operations, and develop new proteomic workflows and products broadly aimed at the life sciences research market.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a commentary at eLife, Brandeis University's Eve Marder calls on researchers to value and pursue truth.

Researchers have developed a way to quickly edit white blood cells, according to the New York Times.

In Science this week: rice gene enables plants to grow quickly in times of flooding, and more.

Education-linked genetic variants could also predict a small portion of a person's social mobility, Newsweek reports.

Sponsored by

This webinar will discuss an automated, high-throughput method of generating high-quality antigens and antibodies.